Cargando…
Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression
OBJECTIVE: There is an urgent need to assess the impact of immunosuppressive therapies on the immunogenicity and efficacy of SARS-CoV-2 vaccination. METHODS: Serological and T-cell ELISpot assays were used to assess the response to first-dose and second-dose SARS-CoV-2 vaccine (with either BNT162b2...
Autores principales: | Prendecki, Maria, Clarke, Candice, Edwards, Helena, McIntyre, Stacey, Mortimer, Paige, Gleeson, Sarah, Martin, Paul, Thomson, Tina, Randell, Paul, Shah, Anand, Singanayagam, Aran, Lightstone, Liz, Cox, Alison, Kelleher, Peter, Willicombe, Michelle, McAdoo, Stephen P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350975/ https://www.ncbi.nlm.nih.gov/pubmed/34362747 http://dx.doi.org/10.1136/annrheumdis-2021-220626 |
Ejemplares similares
-
Comparison of immunogenicity and clinical effectiveness between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in people with end-stage kidney disease receiving haemodialysis: A prospective, observational cohort study
por: Martin, Paul, et al.
Publicado: (2022) -
Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients
por: Prendecki, Maria, et al.
Publicado: (2021) -
Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine
por: Prendecki, Maria, et al.
Publicado: (2021) -
Comparison of Vaccine Effectiveness Against the Omicron (B.1.1.529) Variant in Hemodialysis Patients
por: Spensley, Katrina J., et al.
Publicado: (2022) -
Lack of seroresponse to SARS-CoV-2 booster vaccines given early post-transplant in patients primed pre-transplantation
por: Gleeson, Sarah, et al.
Publicado: (2023)